We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.36B
AUM Growth
-$521M
Cap. Flow
-$561M
Cap. Flow %
-16.68%
Top 10 Hldgs %
31.32%
Holding
2,193
New
694
Increased
377
Reduced
430
Closed
579
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEA icon
1201
Lear
LEA
$8.18B
$288K 0.01%
+1,644
New +$304K
LW icon
1202
Lamb Weston
LW
$7.19B
$287K 0.01%
3,556
-300
-8% -$24K
SOGO
1203
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$286K 0.01%
33,500
+5,100
+18% +$42.7K
DIN icon
1204
Dine Brands
DIN
$452M
$285K 0.01%
+3,195
New +$296K
NOK icon
1205
CALL
Nokia
NOK
$52.3B
$284K 0.01%
63,100
-51,700
-45% -$249K
SBSW icon
1206
Sibanye-Stillwater
SBSW
$7.53B
$284K 0.01%
17,000
-13,216
-44% -$245K
BMBL icon
1207
Bumble
BMBL
$373M
$283K 0.01%
+4,915
New +$259K
PINS icon
1208
Pinterest
PINS
$13.4B
$283K 0.01%
+3,583
New +$250K
SKT icon
1209
CALL
Tanger
SKT
$4.52B
$283K 0.01%
+15,000
New +$263K
EEM icon
1210
PUT
iShares MSCI Emerging Markets ETF
EEM
$30B
$281K 0.01%
5,100
-30,000
-85% -$1.63M
VICI icon
1211
VICI Properties
VICI
$29.4B
$281K 0.01%
9,169
-11,965
-57% -$371K
APLS
1212
DELISTED
Apellis Pharmaceuticals
APLS
$280K 0.01%
4,434
-10,957
-71% -$565K
PARA
1213
CALL
DELISTED
Paramount Global Class B
PARA
$280K 0.01%
6,200
-46,600
-88% -$1.92M
EXR icon
1214
Extra Space Storage
EXR
$31.6B
$278K 0.01%
1,695
-4,316
-72% -$647K
MTUM icon
1215
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
$278K 0.01%
+1,604
New +$272K
ESM.U
1216
DELISTED
ESM Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ESM.U
$278K 0.01%
27,750
-10,000
-26% -$100K
SCOA
1217
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
$278K 0.01%
28,463
RGA icon
1218
Reinsurance Group of America
RGA
$16.1B
$277K 0.01%
+2,428
New +$306K
WST icon
1219
West Pharmaceutical
WST
$24.9B
$277K 0.01%
+771
New +$255K
FAST icon
1220
Fastenal
FAST
$59.5B
$275K 0.01%
+10,562
New +$275K
AZTA icon
1221
Azenta
AZTA
$1.48B
$274K 0.01%
+2,878
New +$279K
PII icon
1222
Polaris
PII
$4.07B
$274K 0.01%
2,000
-3,300
-62% -$447K
VIST icon
1223
Vista Energy
VIST
$7.32B
$274K 0.01%
66,800
-3,200
-5% -$10.2K
SAGE
1224
DELISTED
Sage Therapeutics
SAGE
$273K 0.01%
+4,812
New +$340K
TSCO icon
1225
Tractor Supply
TSCO
$18B
$273K 0.01%
7,335
-385
-5% -$14.1K

Similar funds

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

  • Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
  • Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
  • Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
  • Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
  • Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
  • Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.